The Lead Episode 160: A Discussion of Real-time smartphone alerts during atrial fibrillation episodes with implantable cardiac monitors and wearable devices: SMART-ALERT study
Availability
On-Demand
Cost
$0.00
Credit Offered
No Credit Offered

Recorded at EHRA 2026, this episode of The Lead features host Michael S. Lloyd, MD, FHRS, in conversation with Tina Baykaner, MD, MPH, and Kenneth Ellenbogen, MD, FHRS, about the journal article, Real-time smartphone alerts during atrial fibrillation episodes with implantable cardiac monitors and wearable devices: SMART-ALERT study. Together, they discuss the study findings and explore the use of real-time smartphone alerts in conjunction with implantable cardiac monitors and wearable devices during atrial fibrillation episodes.

  • Review the design and key findings of the SMART-ALERT study evaluating real-time smartphone alerts during atrial fibrillation episodes.
  • Discuss the use of implantable cardiac monitors and wearable devices for real-time detection and notification of atrial fibrillation episodes.
  • Explore the potential clinical implications of integrating smartphone alerts with cardiac monitoring technologies.

Podcast Contributors

Host: Michael S. Lloyd, MD, FHRS

 

Guests:

Tina Baykaner, MD, MPH

Kenneth A. Ellenbogen, MD, FHRS

All relevant financial relationships have been mitigated.

Host and Contributor Disclosure(s):

M. Lloyd

  • Honoraria/Speaking/Consulting Fee: Medtronic, Boston Scientific, Other

 

T. Baykaner

  • Honoraria/Speaking/Consulting Fee: Volta Medical, Medtronic, Pacemate, Johnson & Johnson, Abbott Medical, Boston Scientific
  • Research: NIH, Boston Scientific

 

K. Ellenbogen

  • Honoraria/Speaking/Consulting Fee: American College of Cardiology, Heart Rhythm Society, Boston Scientific, Medtronic, Inc., Abbott
  • Royalty Income: Wiley-Blackwell, Elsevier


Staff Disclosu
re(s) (note: HRS staff are NOT in control of educational content. Disclosures are provided solely for full transparency to the learner):

S. Sailor: No relevant financial relationships with ineligible companies to disclose.
E. Downward: No relevant financial relationships with ineligible companies to disclose.